25 August 2026
Research funding has partially recovered with the reopening of NIH grants, but new restrictions underscore the need for domestic investment.
23 August 2026
The pharmaceutical manufacturing crisis is worsening as procurement policies, rising costs, and imports threaten medicine supply.
6 August 2026
The reduction in PEPFAR funding has led to a decrease in HIV services worldwide and put access to treatment and prevention programmes at risk.
5 August 2026
Lenacapavir production moves closer in SA as three local pharmaceutical manufacturers are shortlisted to produce the HIV-prevention injection.
27 April 2026
A new Physicians for Human Rights report warns that recent HIV funding cuts are jeopardising SA's rollout of the lenacapavir injection.
7 January 2026
South Africa aims to begin generic Lenacapavir manufacturing by 2027. Read how the government plans to scale local production.
30 December 2025
Learn how long-acting injectable PrEP can transform HIV responses in South Africa while bridging treatment access gaps.
24 November 2025
South Africa doubles its pledge to the Global Fund replenishment, aiming to combat HIV, TB, and malaria effectively.
19 November 2025
Uncover the details of the Hetero price collusion probe as the Competition Commission examines key drug procurement allegations.
10 November 2025
Examine the dangers of inadequate health funding in South Africa and the potential diversion of critical resources.
9 November 2025
Learn about global inequity prolonging epidemics and how it hinders pandemic preparedness and increases outbreak risks.